Software stocks are shaking off AI jitters as Microsoft shares break above their 200-day moving average Shares of Microsoft broke above their 200-day moving average for the first time since January.
Salesforce agreed to acquire Contentful, a content management platform for creating and deploying digital content. The software company said Monday it will integrate Contentful into its operations, ...
Norfolk Southern's number-two executive, John Orr, is leaving the freight railroad, which is gearing up for a $71.5 billion merger with Union Pacific. Norfolk Southern on Monday said Orr has resigned ...
Autohome is China’s largest automobile online media platform in terms of user traffic. The firm started providing media services in 2008 with a focus on new car ...
Trading veteran Kevin Muir, author of the Macro Tourist on Substack, raises questions about true demand for artificial intelligence Many heavyweight companies are all-in on AI, but is that really ...
We believe AutoZone’s strategy of leveraging its dominant do-it-yourself retail core to fund aggressive expansion into the commercial do-it-for-me segment has been highly effective. Its roughly 7,700 ...
OTTAWA--Canada's economy is struggling. But let's not call it a recession, economists say. The recession chatter in Canada shifted into high gear after Friday's data indicating Canada's gross domestic ...
Australian Clinical Labs' strategy centers on capitalizing on the growing demand for diagnostic testing. Volume growth is underpinned by population growth, aging demographics, higher incidence of ...
Shares of major software companies logged gains after Nvidia Chief Executive Jensen Huang said artificial-intelligence agents had the potential to significantly boost the sector, brushing aside fears ...
'The neighbor estimates damage from the tree at approximately $6,000 or more' "Small-claims litigation appears possible, particularly since Brian has mentioned that a relative is an attorney." Dear ...
The highly anticipated study found that ivonescimab reduced the risk of death by 34% compared with another drug Summit Therapeutics and Akeso shared more data for their experimental lung-cancer drug ...
Haisco Pharmaceutical Group has formed a licensing and research collaboration with Eli Lilly that is potentially worth more than $3 billion to the Chinese pharmaceutical company. The Shenzhen-listed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results